Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ICE vs GSK✓SelectedUSD · GSKICE vs GSK performance historyLatest closeAs of-0.12%11/16
Stock and ETF performance explorer

ICE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+272.0%
GSK return
+107.3%
Excess return
+164.7%
Maximum drawdown
-34.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.1%-0.1%0.0%-0.1%
7D+2.4%-1.3%+3.8%+2.8%
30D+10.4%+2.7%+7.6%+9.4%
3M+15.6%+2.7%+12.9%+14.4%
6M+16.3%+3.3%+13.0%+14.7%
YTD+11.2%+6.5%+4.8%+7.9%
1Y+18.8%+10.7%+8.1%+13.8%
3Y+64.9%+64.4%+0.5%+33.3%
5Y+39.9%+46.7%-6.8%+16.4%
10Y+272.0%+109.4%+162.7%+177.3%
All+272.0%+107.3%+164.7%+177.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling